MOLECULAR GENETICS OF INHERITED NEUROLOGIC AND PSYCHIATRIC DISORDERS

遗传性神经和精神疾病的分子遗传学

基本信息

项目摘要

We are searching for genes involved in neurologic and psychiatric disorders, with a particular emphasis on bipolar affective disorder and schizophrenia. The clinical heterogeneity seen within these inherited disorders is likely due to environmental influences as well as mutations in genes (multifactorial). Molecular techniques are used to identify mutations that may be predictive of different phenotypes and to understand the molecular mechanisms leading to nervous system abnormalities. We have isolated and characterized genes, such as the neurotransmitter biosynthetic enzymes human tyrosine hydroxylase and tryptophan hydroxylase, that may be involved in neuropsychiatric disorders. Using restriction length fragment polymorphisms (RFLP) and microsatellite DNA markers, we are genotyping DNA from individuals in large families where there is a high risk for affective disorder and we are performing linkage analysis in order to identify chromosome regions harboring susceptibility or protective genes involved in bipolar affective disorder (see Project #Z01 MH 02625-07 NS). For the chromosome regions that are identified expressed sequences will be isolated and characterized. Human genomic DNA containing trinucleotide repeats is being isolated and characterized. We have found a trinucleotide repeat on chromosome 17q that accounts for most expansions detected by the Repeat-Expansion Detection (RED) technique. Cytogenetic studies, including fluorescent in-situ hybridization (FISH), on cells from individuals affected with bipolar affective disorder, schizophrenia (particularly childhood onset, see Project #MH-02581-07 CHP), mental retardation, autism, and attention deficit hyperactivity disorder (ADHD), are being performed to identify chromosomal abnormalities that may aid in the identification of disease genes. We have identified chromosome 22q11.2 interstitial deletions among childhood onset schizophrenics, and also the association of an X-chromosome dodecamer insertional variant allele with mental retardation. The results of this research should provide a molecular basis for diagnosis and for the development of novel therapeutic strategies for these disorders.
我们正在寻找与神经系统相关的基因, 和精神疾病,特别是双相情感障碍 情感障碍和精神分裂症。临床异质性 在这些遗传性疾病中,可能是由于环境 影响以及基因突变(多因素)。分子 技术用于鉴定可能预测 不同的表型,并了解分子机制 导致神经系统异常我们已经分离出 特征基因,如神经递质生物合成 酶人酪氨酸羟化酶和色氨酸羟化酶, 可能与神经精神疾病有关使用 限制性长度片段多态性(RFLP), 微卫星DNA标记,我们正在对来自 在大家庭中,有高风险的情感 我们正在进行连锁分析,以确定 携带易感基因或保护基因的染色体区域 参与双相情感障碍(见项目#Z01 MH 02625-07 NS)。对于被识别的染色体区域 表达的序列将被分离和表征。人类 含有三核苷酸重复序列的基因组DNA正在被分离, 表征了我们发现了一个三核苷酸重复序列, 染色体17 q,占大多数扩增检测到的 重复扩增检测(RED)技术。细胞遗传学研究, 包括荧光原位杂交(FISH), 患有双相情感障碍、精神分裂症 (尤其是儿童期发作,见项目#MH-02581-07 CHP), 智力迟钝、自闭症和注意力缺陷多动 多动症(ADHD),正在进行,以确定染色体 可能有助于识别疾病基因的异常。我们 已经确定了染色体22q11.2间质缺失, 儿童期精神分裂症患者,以及 X染色体十二聚体插入变异等位基因 迟钝这项研究的结果应该提供一个分子 诊断和开发新型治疗药物的基础 这些疾病的治疗策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EDWARD I GINNS其他文献

EDWARD I GINNS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EDWARD I GINNS', 18)}}的其他基金

A Novel Orally Administered Macrophage Delivered Gene Therapy for Gaucher Disease
一种新型口服巨噬细胞治疗戈谢病的基因疗法
  • 批准号:
    7340503
  • 财政年份:
    2006
  • 资助金额:
    --
  • 项目类别:
A Novel Orally Administered Macrophage Delivered Gene Therapy for Gaucher Disease
一种新型口服巨噬细胞治疗戈谢病的基因疗法
  • 批准号:
    7547743
  • 财政年份:
    2006
  • 资助金额:
    --
  • 项目类别:
A Novel Orally Administered Macrophage Delivered Gene Therapy for Gaucher Disease
一种新型口服巨噬细胞治疗戈谢病的基因疗法
  • 批准号:
    7752542
  • 财政年份:
    2006
  • 资助金额:
    --
  • 项目类别:
A Novel Orally Administered Macrophage Delivered Gene Therapy for Gaucher Disease
一种新型口服巨噬细胞治疗戈谢病的基因疗法
  • 批准号:
    7164431
  • 财政年份:
    2006
  • 资助金额:
    --
  • 项目类别:
Novel Orally Administered Macrophage Delivered Gene Ther
新型口服巨噬细胞传递基因疗法
  • 批准号:
    7022537
  • 财政年份:
    2006
  • 资助金额:
    --
  • 项目类别:
Glucocerebrosidase Gene Transfer to the Nervous System
葡萄糖脑苷脂酶基因转移至神经系统
  • 批准号:
    6642183
  • 财政年份:
    2002
  • 资助金额:
    --
  • 项目类别:
SEARCH FOR DNA MARKERS LINKED TO MANIC DEPRESSIVE ILLNESS IN THE OLD ORDER AMISH
在旧秩序阿米什人中寻找与躁狂抑郁症相关的 DNA 标记
  • 批准号:
    6111168
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
TRANSGENIC ANIMAL MODELS OF HUMAN INHERITED DISORDERS
人类遗传性疾病的转基因动物模型
  • 批准号:
    6432827
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
CORRECTION OF INHERITED PROTEIN DEFICIENCEIS BY GENE THERAPY
通过基因疗法纠正遗传性蛋白质缺陷
  • 批准号:
    6111134
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
CORRECTION OF INHERITED PROTEIN DEFICIENCEIS BY GENE THERAPY
通过基因疗法纠正遗传性蛋白质缺陷
  • 批准号:
    6290532
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Exploring the Impact of Clinical Diagnosis on Health and Education Outcomes for Children Receiving Special Educational Needs support for Autism
探索临床诊断对接受自闭症特殊教育需求支持的儿童的健康和教育结果的影响
  • 批准号:
    ES/Z502431/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
PHENOCADES: Developmental neurodynamics of phenotypic cascades in autism and ADHD
现象:自闭症和多动症表型级联的发育神经动力学
  • 批准号:
    EP/Z000319/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
The neural underpinnings of speech and nonspeech auditory processing in autism: Implications for language
自闭症患者言语和非言语听觉处理的神经基础:对语言的影响
  • 批准号:
    10827051
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
Elucidating the role of Cnot3 in regulating social behavior in Autism Spectrum Disorder
阐明 Cnot3 在调节自闭症谱系障碍社会行为中的作用
  • 批准号:
    24K18632
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Diagnostic and Therapeutic Potential of Circular RNAs in Autism Spectrum Disorder
环状 RNA 在自闭症谱系障碍中的诊断和治疗潜力
  • 批准号:
    24K10503
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
EPIGENETIC-GENETIC-MENTAL HEALTH CASCADE BASED PERSONALISED PREVENTION OF NONCOMMUNICABLE DISEASE IN ADOLESCENTS DIAGNOSED WITH AUTISM (ETHEREAL)
基于表观遗传-遗传-心理健康级联的个性化预防自闭症青少年非传染性疾病(ETHEREAL)
  • 批准号:
    10063676
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
Advancing the Autism Knowledge Synthesis Initiative: A Review of Canadian Provinces and Territories Autism Policies, Programs and Services
推进自闭症知识综合计划:加拿大各省和地区自闭症政策、计划和服务回顾
  • 批准号:
    484621
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Fellowship Programs
Transforming Autism Research and Policy at the National Level: A Program for Evidence-Based Solutions and Inclusive Research
国家层面自闭症研究和政策的转变:循证解决方案和包容性研究计划
  • 批准号:
    487457
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Salary Programs
Building multisectoral capacity to plan for the development and evaluation of an interactive, inclusive and patient-centered knowledge transfer tool to reduce stigma around autism
建立多部门能力,规划开发和评估交互式、包容性和以患者为中心的知识转移工具,以减少自闭症的耻辱
  • 批准号:
    487939
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Miscellaneous Programs
Self-recognition in children with autism spectrum disorder: Investigating of the cognitive and neural basis using MEG
自闭症谱系障碍儿童的自我认知:使用 MEG 研究认知和神经基础
  • 批准号:
    23K06789
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了